UPDATED May 08, 2024
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AMGN | US$307.31 | 2.3% | 31.3% | US$161.1b | US$313.31 | PE43.8x | E17.8% | 2.9% | ||
PFE | US$28.27 | 1.8% | -26.2% | US$157.2b | US$31.89 | PS2.9x | E29.7% | 5.9% | ||
VRTX | US$418.82 | 2.1% | 19.6% | US$105.9b | US$462.09 | PE26.9x | E10.2% | n/a | ||
TEVA | US$15.74 | 12.8% | 88.5% | US$15.8b | US$15.74 | PS1.1x | E31.4% | 0% | ||
ELAN | US$16.89 | 24.9% | 87.7% | US$6.7b | US$17.93 | PS1.9x | E81.6% | n/a | ||
GRPH | US$22.26 | 580.7% | 861.6% | US$190.4m | n/a | PB7.1x | E36.4% | n/a | ||
DHR | US$249.55 | 0.3% | 6.9% | US$184.3b | US$272.68 | PE45.4x | E13.5% | 0.4% | ||
JNJ | US$148.95 | 0.2% | -7.9% | US$357.9b | US$173.26 | PE21x | E6.6% | 3.3% | ||
MYGN | US$23.95 | 21.1% | 36.4% | US$2.2b | US$25.10 | PS2.8x | E64.7% | n/a | ||
A | US$142.80 | 1.1% | 11.5% | US$41.4b | US$150.94 | PE33.9x | E9.0% | 0.7% | ||
BGNE | US$164.44 | 2.4% | -32.9% | US$16.8b | US$267.97 | PS6.2x | E59.7% | n/a | ||
MRNA | US$121.89 | 0.7% | -6.8% | US$46.4b | US$138.67 | PS9.1x | E68.7% | n/a | ||
TMO | US$573.64 | 0.1% | 7.5% | US$218.7b | US$625.47 | PE36.3x | E10.6% | 0.3% | ||
DNLI | US$18.90 | 12.2% | -33.4% | US$2.4b | US$39.07 | PS9.1x | E12.0% | n/a | ||
CRNX | US$50.89 | 6.8% | 118.0% | US$3.8b | US$59.79 | PS998.6x | E8.9% | n/a | ||
PCRX | US$29.65 | 11.8% | -30.9% | US$1.2b | US$45.55 | PE19.6x | E25.6% | n/a | ||
PRGO | US$31.11 | 3.2% | -12.4% | US$4.2b | US$39.50 | PE5301.2x | E49.3% | 3.5% | ||
LGND | US$80.36 | 9.8% | 3.6% | US$1.3b | US$116.80 | PE15x | E-37.8% | n/a | ||
BIIB | US$219.72 | 0.4% | -29.9% | US$31.9b | US$285.92 | PE27.4x | E17.8% | n/a | ||
MTD | US$1,253.13 | 0.4% | -8.7% | US$26.7b | US$1,177.70 | PE34x | E7.7% | n/a | ||
VTRS | US$11.81 | 0.8% | 23.1% | US$13.9b | US$12.46 | PE256.4x | E16.8% | 4.1% | ||
HALO | US$42.01 | 1.9% | 21.8% | US$5.2b | US$51.44 | PE16.7x | E19.7% | n/a | ||
CORT | US$25.40 | 3.8% | 5.8% | US$2.5b | US$43.60 | PE22.6x | E26.4% | n/a | ||
PTGX | US$27.11 | 5.1% | 9.7% | US$1.6b | US$43.50 | PE9.8x | E16.9% | n/a |